Shares of Enlight Renewable Energy surged 9.5% in pre-market trading to $70.91 after the Israel-based clean-energy developer posted record third-quarter results and raised its full-year outlook for the second time in 2026. The beat is clear—but the valuation math behind a stock trading at roughly 103 times earnings demands scrutiny.
A Clean Beat That Topped Every Headline Number
Revenue and income rose 40% year over year to $231 million , while adjusted EBITDA climbed 38% to $154 million . Earnings came in at $0.20 per share, beating the consensus estimate of $0.13 by $0.07 . The results reflected newly operational projects, stronger electricity trading activity in Israel, and favorable exchange-rate movements . For shareholders, the outperformance signals that Enlight's pipeline of solar, wind, and battery-storage projects is converting from blueprints into cash faster than Wall Street expected.
Raised Guidance Signals Confidence—but Not by a Landslide
Management lifted full-year 2026 revenue guidance to $810–$830 million and adjusted EBITDA guidance to $575–$590 million . That's a modest bump from the prior $790–$820 million revenue range. Operating cash flow hit roughly $104 million in Q3, up 26% year over year , an increasingly important signal that Enlight can partially self-fund growth rather than relying entirely on outside capital.
A $5.6 Billion Debt Load Looms Behind the Growth Story
Total long-term debt stands at $5.6 billion, with 80% structured as non-recourse project finance —meaning lenders can only claim individual project assets, not the parent company. Though 86% of the debt is hedged at fixed rates, the absolute size warrants attention as Enlight expands into four new European markets . The spread between borrowing costs and project returns is still favorable, per management, but any shift in interest rates could squeeze future margins.
Analyst Opinion Remains Deeply Split
The stock carries an average "hold" rating with a consensus price target of $75.29 —barely above today's pre-market price. Barclays is bullish at $89 , while Mizuho holds an "underperform" rating with a $41 target . Mizuho argues the stock already prices in "full conversion of the development pipeline and premium valuation assumptions beyond 2030" . At a P/E above 100, the stock's PEG ratio of 0.38 suggests growth may compensate—but only if execution stays flawless .